Thyroid Eye Disease clinical trials at UCSD

1 research study open to eligible people

Showing trials for

  • A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

    open to eligible people ages 18 years and up

    The overall objective is to investigate the efficacy, safety and tolerability of TEPEZZA® in participants with chronic (inactive) TED (thyroid eye disease). Approximately 57 participants will be enrolled. There will be a treatment period (through Week 24) and a follow up period (where TEPEZZA will not be infused).

    La Jolla, California and other locations

Last updated: